red inflammation on the injection site; red inflammation on the injection site; could not breath/lungs were tight; throat hurt; Ears hurt; body hurt; Fatigue; nausea; vomiting; Not feeling herself; Pain at injection site; numbness/tightness of the fingers on the same side which rose to the arm, shoulder and neck; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness/tightness of the fingers on the same side which rose to the arm, shoulder and neck), OROPHARYNGEAL PAIN (throat hurt), EAR PAIN (Ears hurt), VACCINATION COMPLICATION (Not feeling herself) and PAIN (body hurt) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.).    On 04-Jan-2021 at 11:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced HYPOAESTHESIA (numbness/tightness of the fingers on the same side which rose to the arm, shoulder and neck) and VACCINATION SITE PAIN (Pain at injection site). On 05-Jan-2021, the patient experienced VACCINATION COMPLICATION (Not feeling herself). On 07-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (throat hurt), EAR PAIN (Ears hurt), PAIN (body hurt), FATIGUE (Fatigue), NAUSEA (nausea) and VOMITING (vomiting). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (red inflammation on the injection site) and VACCINATION SITE SWELLING (red inflammation on the injection site). On 04-Jan-2021, HYPOAESTHESIA (numbness/tightness of the fingers on the same side which rose to the arm, shoulder and neck) and VACCINATION SITE PAIN (Pain at injection site) had resolved. At the time of the report, OROPHARYNGEAL PAIN (throat hurt), EAR PAIN (Ears hurt), VACCINATION COMPLICATION (Not feeling herself), PAIN (body hurt), FATIGUE (Fatigue), NAUSEA (nausea) and VOMITING (vomiting) outcome was unknown and VACCINATION SITE ERYTHEMA (red inflammation on the injection site) and VACCINATION SITE SWELLING (red inflammation on the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication includes Tylenol and albuterol inhalation. Concomitant product use was not provided.  This case concerns a 57-year-old female with nonserious unexpected dyspnea, hypoaesthesia, pain, ear pain, throat pain, vaccination related malaise, and expected fatigue, nausea, vomiting, vaccination site pain, vaccination site erythema, vaccination site swelling. Event onset the same day as first dose mRNA-1273. Events resolved. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: This case concerns a 57-year-old female with nonserious unexpected dyspnea, hypoaesthesia, pain, ear pain, throat pain, vaccination related malaise, and expected fatigue, nausea, vomiting, vaccination site pain, vaccination site erythema, vaccination site swelling. Event onset the same day as first dose mRNA-1273. Events resolved. Based on current available information and temporal association between use of the product and the start date of the event, a causal relationship cannot be excluded.